Daniel Kofi Nyame

Mr. Daniel Kofi Nyame

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2026 in Exploration of Drug Science
Verified
Journal Article
Open access
PDF file
DNDaniel Kofi Nyame
Daniel Kofi Nyame
VBVongai Baye
Vongai Baye
IKIbrahim Joel Kamara
Ibrahim Joel Kamara
XZXiaohui Zhou
Xiaohui Zhou
Immunotherapy has transformed oncology, yet has only been marginally effective in prostate cancer (PCa), which is a malignancy with a low mutational load and a highly immunosuppressive tumor microenvironment (TME). This critical review is a reflection on the changing position of the innovative immunotherapies in PCa that extends beyond the description stage to synthesize the synergies and constraints of immune checkpoint inhibitors (ICIs), chimeric antigen receptor (CAR) T-cell therapy, and next-generation modalities such as bispecific T-cell engagers (BiTEs). We assess the mechanistic reasoning of combination therapies, comprising androgen receptor signaling communicators, PARP communicators, and radioligand therapies, which seek to modulate the immunogenicity of the immune-cold PCa TME. Also, we combine new knowledge to novel resistance pathways, including the newly discovered thrombospondin-1-CD47 axis, in the process of T cell exhaustion through calcineurin-NFAT signaling. Although some preclinical data and initial clinical indicators in biomarker-selected subpopulations are promising, the vast majority of Phase III trials of ICIs in unselected populations with metastatic castration-resistant prostate cancer (mCRPC) have failed. This review reveals that the next generation of PCa immunotherapy would not be sequential monotherapies but rather rationally designed multimodal combinations guided by profound molecular and immune profiling to overcome inherent resistance mechanisms.

26 February 2026 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
DNDaniel Kofi Nyame
Daniel Kofi Nyame
XZXiaohui Zhou
Xiaohui Zhou

16 April 2026 in Exploration of Immunology
Verified
Journal Article
Open access
PDF file
DNDaniel Kofi Nyame
Daniel Kofi Nyame
FGFrancis Goku
Francis Goku
EFEmmanuel Delali Kofi Fiagbey
Emmanuel Delali Kofi Fiagbey
AAAshna Asim
Ashna Asim
BOBrian Roy Ogony
Brian Roy Ogony
XZXiaohui Zhou
Xiaohui Zhou
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a debilitating condition of the urogenital system, with an elusive and multifactorial pathogenesis. Recent data show that there is a potential interplay between dysregulated autophagy and altered exosomal communication that may contribute to the persistent inflammation and pain characteristic of CP/CPPS. This review synthesizes recent advances to propose a hypothetical model: cellular stress in the prostate may trigger dysfunctional autophagy, which could reprogram secreted exosomes biogenesis and cargo in a series of lipid-raft microdomain-involved mechanisms and secretory autophagy. The outcomes of this process include the release of pro-inflammatory cytokines (e.g., IL-1β, TNF-α) enriched exosomes, damage-associated molecular patterns (DAMPs), microRNAs (e.g., miR-155), and fibrotic mediators (e.g., TGF-β1). These signalosomes are hypothesized to transmit the inflammatory and nociceptive signals and may contribute to coordinating the dysregulation of immune cells (such as the M1 polarization of macrophages), sensitization of neurons, and tissue fibrosis, thereby potentially perpetuating the presence of a chronic disease. We critically assess the available evidence based on human studies, animal models, and in vitro systems, but recognize that there is a present requirement for additional CP/CPPS-specific mechanistic evidence. Furthermore, we explore the translational implications of this axis, discussing its promise for yielding novel exosome-based diagnostic biomarkers and its potential as a therapeutic target, while also highlighting the significant preclinical challenges and risks that must be overcome. Ultimately, the autophagy-exosome axis presents a new, integrative concept of CP/CPPS, which shifts the paradigm to the mechanisms of intercellular communication and provides new possibilities to carry out mechanism-selective research and future treatment options.

17 June 2026 in Exploration of Cardiology
Verified
Journal Article
Open access
EFEmmanuel Delali Kofi Fiagbey
Emmanuel Delali Kofi Fiagbey
JWJiawen Wang
Jiawen Wang
SSSalama Habibu Saad
Salama Habibu Saad
TFTianling Feng
Tianling Feng
ZKZikomo Gaudence Kipanga
Zikomo Gaudence Kipanga
JZJianjun Zou
Jianjun Zou
Aim: Low cardiac output syndrome (LCOS) may be improvable; hence, timely detection and intervention are essential. However, no model has been established for the prediction of LCOS onset post non-isolated coronary artery bypass grafting (CABG) surgery. Therefore, this study aimed to develop a machine-learning-based model to predict LCOS after non-isolated CABG. Methods: A total of 378 patients who underwent non-isolated CABG at Nanjing First Hospital, China, were retrospectively assessed. Five algorithms [L2 regularized logistic regression (LR), random forest (RF) classifier, extreme gradient boosting (XGB), light gradient boosting machine (LGBM), and support vector machine (SVM)] were employed. Model performance and clinical utility were evaluated using area under the curve (AUC), 10-fold cross-validation, and decision curve analysis (DCA). SHapley Additive exPlanations (SHAP) were used to assess the model’s interpretability. A web calculator was developed. Results: XGB showed superior performance and calibration (AUC: 0.933, 95% CI: 0.903–0.962; Brier score of 0.107), with excellent specificity (0.865), accuracy (0.860), and precision (0.753). In testing, XGB maintained excellent discrimination (AUC: 0.868, 95% CI: 0.799–0.936), best specificity (0.785), accuracy (0.781), and precision (0.614). DCA confirmed clinical usefulness. SHAP analysis identified the ejection fraction, left ventricular end-systolic diameter, and lactate levels as the most influential predictors. The web calculator is accessible via https://lcos-cabg-xgb-model.streamlit.app/ Conclusions: The developed web-based XGB model effectively predicts LCOS after non-isolated CABG, aiding early risk stratification and detection.